← Eichor
Condition: Avp Deficiency Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Avp Deficiency

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07569861
Ilaris NIS in Korea
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT06838143
Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency
Phase 1 · 1 location(s) · Elizabeth Austen Lawson · NCT04789148
Plasma Oxytocin Response to Oral Estrogens in Healthy Controls and AVP-Deficiency
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07361263
Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease
EARLY_Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT07568509
Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Control
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06808516
The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT06742060
Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus
Phase 2 · 3 location(s) · University Hospital, Basel, Switzerland · NCT06036004
Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT07276152
Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patient
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT06676774
National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and He
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT06789705
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.